Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02714751
Other study ID # CIR2015/057
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2016
Est. completion date March 2019

Study information

Verified date April 2019
Source Corporacion Parc Tauli
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Mechanical ventilation (MV) if a life-support treatment for critically ill patients that can develop adverse effects. Patient-ventilator asynchronies can be present from the beginning of MV, it can be associated with poor outcome and it can develop clinical changes. The aim of this study is to evaluate if the knowledge of the presence of asynchronies by the healthcare team can help to reduce its incidence, improving outcomes of critically ill patients.

A prospective, single-center, before and after study will be conducted in the ICU of Hospital de Sabadell. The study will have 2 phases: a first observational period where the incidence of asynchronies will be assessed, and a second period where a daily information of the presence of asynchronies to the healthcare team will be done with the aim to reduce the incidence.

A continous record of asynchronies and clinical variables will be done during ICU stay.


Recruitment information / eligibility

Status Completed
Enrollment 166
Est. completion date March 2019
Est. primary completion date March 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Invasive mechanical ventilation < 24 hours.

- > 18 years-old

Exclusion Criteria:

- > 24 hours of invasive mechanical ventilation at admission.

- <48 hours of data collected

- Informed consent not obtained

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Daily asynchronies information


Locations

Country Name City State
Spain Parc Tauli Sabadell

Sponsors (1)

Lead Sponsor Collaborator
Corporacion Parc Tauli

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of asynchronies one year